← FDA DRUG APPROVALS

FDA NDA · NDA009276

HIWOLFIA

Sponsor: BOWMAN PHARMS

APPLICATION
NDA009276
TYPE
NDA
ORIGINAL APPROVAL
1954-01-28
LATEST ACTION
1954-01-28
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

HIWOLFIADiscontinued
RAUWOLFIA SERPENTINA ROOT 50MG · TABLET · ORAL
HIWOLFIADiscontinued
RAUWOLFIA SERPENTINA ROOT 100MG · TABLET · ORAL
HIWOLFIADiscontinued
RAUWOLFIA SERPENTINA ROOT 50MG · TABLET · ORAL

Approval history

1954-01-28Type 5 - New Formulation or New Manufacturer · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →